Pfizer in talks to buy rival Wyeth for $60 billion: sources

NEW YORK/PHILADELPHIA (Reuters) – Pfizer Inc, the world’s largest drugmaker, is in talks to buy Wyeth in a deal possibly valued at more than $60 billion, sources familiar with the situation said on Friday, sending Wyeth shares up 12.8 percent.

Leave a Reply